These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37865547)

  • 1. Reply to Thomas Seisen, Morgan Rouprêt, Quoc-Dien Trinh, and Joaquim Bellmunt's Letter to the Editor re: Martin Swinton, Neethu Billy Graham Mariam, Jean Ling Tan, et al. Bladder-Sparing Treatment with Radical Dose Radiotherapy Is an Effective Alternative to Radical Cystectomy in Patients with Clinically Node-positive Nonmetastatic Bladder Cancer. J Clin Oncol 2023;41:4406-15.
    Swinton M; Hoskin P; Choudhury A
    Eur Urol; 2024 Jan; 85(1):e22-e23. PubMed ID: 37865547
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Martin Swinton, Neethu Billy Graham Mariam, Jean Ling Tan, et al. Bladder-Sparing Treatment with Radical Dose Radiotherapy Is an Effective Alternative to Radical Cystectomy in Patients with Clinically Node-positive Nonmetastatic Bladder Cancer. J Clin Oncol. 2023;41:4406-4415.
    Seisen T; Rouprêt M; Trinh QD; Bellmunt J
    Eur Urol; 2024 Jan; 85(1):e19-e21. PubMed ID: 37865549
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to Thomas Seisen, Morgan Rouprêt, and Pierre Blanchard's Letter to the Editor re: Alexandre R. Zlotta, Leslie K. Ballas, Andrzej Niemierko, et al. Radical Cystectomy Versus Trimodality Therapy for Muscle-invasive Bladder Cancer: A Multi-institutional Propensity Score Matched and Weighted Analysis. Lancet Oncol 2023;24:669-81.
    Zlotta AR; Lajkosz K; Efstathiou JA
    Eur Urol; 2024 Jan; 85(1):e25-e26. PubMed ID: 37661552
    [No Abstract]   [Full Text] [Related]  

  • 4. Controversy Surrounding Bladder-Sparing Radical Dose Radiotherapy as an Alternative to Radical Cystectomy for Clinically Node-Positive Nonmetastatic Bladder Cancer.
    He W; Zeng S; Xu C
    J Clin Oncol; 2024 Feb; 42(5):614-615. PubMed ID: 38051990
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to Francesco Montorsi, Giuseppe Rosiello, and Giorgio Gandaglia's Letter to the Editor re: Roberto Contieri, Patrick J. Hensley, Wei Shen Tan, et al. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy. Eur Urol Oncol. 2023;6:590-596.
    Contieri R; Hensley PJ; Kamat AM
    Eur Urol Oncol; 2024 Apr; 7(2):301. PubMed ID: 37806840
    [No Abstract]   [Full Text] [Related]  

  • 6. Bladder-Sparing Treatment With Radical Dose Radiotherapy Is an Effective Alternative to Radical Cystectomy in Patients With Clinically Node-Positive Nonmetastatic Bladder Cancer.
    Swinton M; Mariam NBG; Tan JL; Murphy K; Elumalai T; Soni M; Ferrera A; Richardson C; Walshaw R; Mistry H; Ramani V; Song Y; Birtle A; Henry A; Chan J; Hoskin P; Choudhury A
    J Clin Oncol; 2023 Sep; 41(27):4406-4415. PubMed ID: 37478391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reply to Chao Quan, Jinbo Chen, and Jiao Hu's Letter to the Editor re: Giuseppe Basile, Marco Bandini, Ewan A. Gibb, et al. Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Cancer: 3-Year Median Follow-up Update of PURE-01 Trial. Clin Cancer Res 2022;28:5107-14.
    Basile G; Bandini M; Montorsi F; Necchi A
    Eur Urol; 2023 Apr; 83(4):e111-e112. PubMed ID: 36707359
    [No Abstract]   [Full Text] [Related]  

  • 8. Reply to Satoru Taguchi, Tohru Nakagawa, and Hiroshi Fukuhara's Letter to the Editor re: Jürgen E. Gschwend, Matthias M. Heck, Jan Lehmann, et al. Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial. Eur Urol 2019;75:604-11.
    Gschwend JE; Heck M
    Eur Urol; 2019 Aug; 76(2):e37. PubMed ID: 31056229
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply to Bernardo Rocco and Maria Chiara Sighinolfi's Letter to the Editor re: James W.F. Catto, Pramit Khetrapal, Federico Ricciardi, et al. Effect of Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients with Bladder Cancer: A Randomized Clinical Trial. JAMA 2022;327:2092-103: Lacking the Evidence for Neobladder Use After Radical Cystectomy.
    Catto JWF; Khetrapal P; Ambler G; Williams NR; Brew-Graves C; Kelly JD;
    Eur Urol; 2022 Dec; 82(6):e167-e168. PubMed ID: 36114078
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply to Samuel Bishara and Jim Adshead's letter to the editor re: Brian J. Linder, Igor Frank, John C. Cheville, et al. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy. Eur Urol 2013;63:839-45.
    Linder BJ; Boorjian SA
    Eur Urol; 2013 Sep; 64(3):e49-50. PubMed ID: 23787355
    [No Abstract]   [Full Text] [Related]  

  • 11. Reply to Siebren Dijkstra and Carl J. Wijburg's Letter to the Editor re: Bernard H. Bochner, Guido Dalbagni, Karim H. Marzouk, et al. Randomized Trial Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: Oncologic Outcomes. Eur Urol 2018;74:465-71. Can the Pattern of Cancer Recurrence Truly be Assigned to the Surgical Modality?
    Bochner BH; Dalbagni G
    Eur Urol; 2019 May; 75(5):e138-e139. PubMed ID: 30712972
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to Alberto Briganti, Giorgio Gandaglia, Markus Graefen, Steven Joniau, R. Jeffrey Karnes, and Francesco Montorsi's Letter to the Editor re: Jean F.P. Lestingi, Giuliano B. Guglielmetti, Quoc-Dien Trinh, et al. Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial. Eur Urol 2021;79:595-604. Time for a Change? Clinically Meaningful Reasons Why We Will Continue Performing Extended Pelvic Lymph Node Dissection in Selected Patients with Prostate Cancer.
    Lestingi JFP; Trinh QD; Coelho RF; Pontes J; Bastos DA; Nahas WC
    Eur Urol; 2021 Jun; 79(6):e184-e185. PubMed ID: 33685836
    [No Abstract]   [Full Text] [Related]  

  • 13. Similar treatment outcomes for radical cystectomy and radical radiotherapy in invasive bladder cancer treated at a United Kingdom specialist treatment center: in regard to Kotwal et al. (Int J Radiat Oncol Biol Phys 2008;70:456-463).
    Rosario DJ; Catto JW; Cutinha PE; Anderson JB; Ferguson C; Kirkbride P; Hamdy FC
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1601-2; author reply 1602. PubMed ID: 18640506
    [No Abstract]   [Full Text] [Related]  

  • 14. Bladder sparing surgery in high-grade bladder cancer.
    Yakovlev PG; Klyushin DA; Vereshchako RI
    Exp Oncol; 2019 Jun; 41(2):160-165. PubMed ID: 31262149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective bladder preservation with curative intent for muscle-invasive bladder cancer: a contemporary review.
    Koga F; Kihara K
    Int J Urol; 2012 May; 19(5):388-401. PubMed ID: 22409269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Checkpoint inhibitors: the new treatment paradigm for urothelial bladder cancer.
    Katz H; Wassie E; Alsharedi M
    Med Oncol; 2017 Sep; 34(10):170. PubMed ID: 28864844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: Alexandre R. Zlotta, Leslie K. Ballas, Anderzej Niemierko, et al. Radical Cystectomy Versus Trimodality Therapy for Muscle-invasive Bladder Cancer: A Multi-institutional Propensity Score Matched and Weighted Analysis. Lancet Oncol 2023;24:669-81.
    Seisen T; Rouprêt M; Blanchard P
    Eur Urol; 2024 Jan; 85(1):e24. PubMed ID: 37659960
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter to the editor: Long-term survival after female pelvic organ-sparing radical cystectomy versus standard radical cystectomy: a multi-institutional propensity score-matched analysis.
    Chen Y; Liao Y; Yang Y; Zheng X
    Int J Surg; 2024 Feb; 110(2):1289-1290. PubMed ID: 38000058
    [No Abstract]   [Full Text] [Related]  

  • 19. Reply to Michael Froehner, Rainer Koch and Manfred P. Wirth's letter to the editor re: Roman Mayr, Matthias May, Thomas Martini, et al. Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the bladder. Eur Urol 2012;62:662-70.
    Mayr R; May M; Fritsche HM
    Eur Urol; 2013 Jan; 63(1):e10. PubMed ID: 23079054
    [No Abstract]   [Full Text] [Related]  

  • 20. Reply letter to: Peyton CC, Tang D, Reich RR, et al. Downstaging and survival outcomes associated with neoadjuvant chemotherapy regimens among patients treated with cystectomy for muscle-invasive bladder cancer. JAMA Oncol. 2018 Nov 1;4(11):1535-1542.
    Boeri L; Montanari E; Karnes RJ
    World J Urol; 2020 May; 38(5):1341-1342. PubMed ID: 30944970
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.